Pantobex® is prescription medicine in the class of proton pump inhibitors. It is indicated for Acid related disorders. It works by reducing the amount of acid in stomach by inhibiting proton pump. It provides lest drug- drug interaction due to least affinity to Cytochromic Enzyme.
Pantobex Tablet 40 mg
The usual recommended adult oral dose is 40 mg given once daily, preferably in the morning with or without food. The duration of therapy is ranging from 2-8 weeks.
Duodenal ulcers: Pantoprazole 40 mg tablet once daily for 2-4 weeks.
Gastric ulcer: Pantoprazole 40 mg tablet once daily for 4-8 weeks.
Reflux esophagitis: Pantoprazole 40 mg tablet once daily for 4-8 weeks.
Ulcers induced by NSAIDs: Pantoprazole 40 mg tablet once daily.
Maintenance therapy: Maintenance therapy should involve the lowest effective dose of the drug. Pantoprazole both 20 mg & 40 mg doses are safe and effective in maintaining patients with healed reflux esophagitis and PUD in remission.
Pantoprazole 40 IV Injection-
Treatment of Gastroesophageal Reflux Disease associated with a history of erosive esophagitis: The recommended adult dose is 40 mg Pantoprazole given once daily by intravenous infusion for 7 to 10 days. Pathological
Hypersecretion Associated with Zollinger-Ellison Syndrome: The recommended adult dosage is 80 mg q12h. The frequency of dosing can be adjusted to individual patient needs based on acid output measurements.